Skip to main content
SpringerLink
Log in

Intravascular Device-Related Infections: Catheter Salvage Strategies and Prevention of Device-Related Infection

  • Chapter
  • First Online:
Principles and Practice of Cancer Infectious Diseases

Part of the book series: Current Clinical Oncology ((CCO))

  • 1628 Accesses

Abstract

The use of intravascular devices for ­administration of chemotherapeutic drugs, fluids, blood products, and nutritional support is essential to the care of patients with cancer. Unfortunately, intravascular devices have great potential to produce iatrogenic disease, especially bloodstream infection originating from colonization of the device used for access or from contamination of the infusate administered through the device. Over two thirds of all healthcare-associated bacteremias originate from devices for vascular access. Probably, more than any other healthcare-associated infection, IVDR BSI is eminently preventable. The first step to preserve vascular access is a highly effective institutional program for the prevention of IVDR BSI. In recent years, high-quality research studies have delineated key measures for prevention, such as chlorhexidine (CHG) for cutaneous antisepsis, maximal barrier precautions, antiinfective-impregnated catheters, and the use of a CVC insertion “bundle,” and IVDR BSI rates in the ICU have declined markedly in most hospitals. However, despite adherence to best practices, IVDR BSI continues to pose formidable challenges, especially in patients with cancer. Catheter salvage in the context of established IVDR BSI is particularly challenging, but recent advances such as antibiotic lock technique are now providing previously unavailable options.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 259.00
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Raad I, Hachem R, Hanna H, et al. Sources and outcome of bloodstream infections in cancer patients: the role of central venous catheters. Eur J Clin Microbiol Infect Dis. 2007;26(8):549–56.

    PubMed  CAS  Google Scholar 

  2. Hachem R, Raad I. Prevention and management of long-term catheter related infections in cancer patients. Cancer Invest. 2002;20(7–8):1105–13.

    PubMed  Google Scholar 

  3. Longuet P, Douard MC, Arlet G, Molina JM, Benoit C, Leport C. Venous access port-related bacteremia in patients with acquired immunodeficiency syndrome or cancer: the reservoir as a diagnostic and therapeutic tool. Clin Infect Dis. 2001;32(12):1776–83.

    PubMed  CAS  Google Scholar 

  4. Safdar N, Maki DG. Antibiotic resistance and prevention of CVC-associated BSIs, catheter-associated urinary tract infection and clostridium difficile. In: Jarvis W, editor. Bennett and Brachman’s hospital infections. Philadelphia: Lippincott, Williams and Wilkins; 2007. p. 395–416.

    Google Scholar 

  5. Raad I, Hanna H, Maki D. Intravascular catheter-related infections: advances in diagnosis, prevention, and management. Lancet Infect Dis. 2007;7(10):645–57.

    PubMed  Google Scholar 

  6. O’Grady NP, Alexander M, Dellinger EP, et al. Guidelines for the prevention of intravascular catheter-related infections. Infect Control Hosp Epidemiol. 2002;23(12):759–69.

    PubMed  Google Scholar 

  7. Siempos II, Kopterides P, Tsangaris I, Dimopoulou I, Armaganidis AE. Impact of catheter-related bloodstream infections on the mortality of critically ill patients: a meta-analysis. Crit Care Med. 2009;37(7):2283–9.

    PubMed  Google Scholar 

  8. Pittet D, Tarara D, Wenzel RP. Nosocomial bloodstream infection in critically ill patients. Excess length of stay, extra costs, and attributable mortality. JAMA. 1994;271(20):1598–601.

    PubMed  CAS  Google Scholar 

  9. Maki DG, Kluger DM, Crnich CJ. The risk of bloodstream infection in adults with different intravascular devices: a systematic review of 200 published prospective studies. Mayo Clin Proc. 2006;81(9):1159–71.

    PubMed  Google Scholar 

  10. Hockenhull JC, Dwan K, Boland A, et al. The clinical effectiveness and cost-effectiveness of central venous catheters treated with anti-infective agents in preventing bloodstream infections: a systematic review and economic evaluation. Health Technol Assess. 2008;12(12):1–154. Iii–iv, xi–xii.

    Google Scholar 

  11. Raad II. Commentary: zero tolerance for catheter-related bloodstream infections: the unnegotiable objective. Infect Control Hosp Epidemiol. 2008;29(10):951–3.

    PubMed  Google Scholar 

  12. Pronovost P, Needham D, Berenholtz S, et al. An intervention to decrease catheter-related bloodstream infections in the ICU. N Engl J Med. 2006;355(26):2725–32.

    PubMed  CAS  Google Scholar 

  13. McKee C, Berkowitz I, Cosgrove SE, et al. Reduction of catheter-associated bloodstream infections in pediatric patients: experimentation and reality. Pediatr Crit Care Med. 2008;9(1):40–6.

    PubMed  Google Scholar 

  14. Pronovost PJ, Goeschel CA, Colantuoni E, et al. Sustaining reductions in catheter related bloodstream infections in Michigan intensive care units: observational study. BMJ. 2010;340:c309.

    PubMed  Google Scholar 

  15. Centers for Disease Control. Reduction in central line-associated bloodstream infections among patients in intensive care units – Pennsylvania, April 2001–March 2005. MMWR Morb Mortal Wkly Rep. 2005;54(40):1013–6.

    Google Scholar 

  16. Frankel HL, Crede WB, Topal JE, Roumanis SA, Devlin MW, Foley AB. Use of corporate Six Sigma performance-improvement strategies to reduce incidence of catheter-related bloodstream infections in a surgical ICU. J Am Coll Surg. 2005;201(3):349–58.

    PubMed  Google Scholar 

  17. Gastmeier P, Geffers C. Prevention of catheter-related bloodstream infections: analysis of studies published between 2002 and 2005. J Hosp Infect. 2006;64(4):326–35.

    PubMed  CAS  Google Scholar 

  18. Jeffries HE, Mason W, Brewer M, et al. Prevention of central venous catheter-associated bloodstream infections in pediatric intensive care units: a performance improvement collaborative. Infect Control Hosp Epidemiol. 2009;30(7):645–51.

    PubMed  Google Scholar 

  19. Lobo RD, Levin AS, Oliveira MS, et al. Evaluation of interventions to reduce catheter-associated bloodstream infection: continuous tailored education versus one basic lecture. Am J Infect Control. 2010;38:440–8.

    PubMed  Google Scholar 

  20. Miller RS, Norris PR, Jenkins JM, et al. Systems initiatives reduce healthcare-associated infections: a study of 22, 928 device days in a single trauma unit. J Trauma. 2010;68(1):23–31.

    PubMed  Google Scholar 

  21. Render ML, Brungs S, Kotagal U, et al. Evidence-based practice to reduce central line infections. Jt Comm J Qual Patient Saf. 2006;32(5):253–60.

    PubMed  Google Scholar 

  22. Rosenthal VD, Guzman S, Pezzotto SM, Crnich CJ. Effect of an infection control program using education and performance feedback on rates of intravascular device-associated bloodstream infections in intensive care units in Argentina. Am J Infect Control. 2003;31(7):405–9.

    PubMed  Google Scholar 

  23. Zuschneid I, Schwab F, Geffers C, Ruden H, Gastmeier P. Reducing central venous catheter-associated primary bloodstream infections in intensive care units is possible: data from the German nosocomial infection surveillance system. Infect Control Hosp Epidemiol. 2003;24(7):501–5.

    PubMed  Google Scholar 

  24. Edwards JR, Peterson KD, Andrus ML, Dudeck MA, Pollock DA, Horan TC. National Healthcare Safety Network (NHSN) report, data summary for 2006 through 2007, issued November 2008. Am J Infect Control. 2008;36(9):609–26.

    PubMed  Google Scholar 

  25. Edwards JR, Peterson KD, Andrus ML, et al. National Healthcare Safety Network (NHSN) report, data summary for 2006, issued June 2007. Am J Infect Control. 2007;35(5):290–301.

    PubMed  Google Scholar 

  26. Edwards JR, Peterson KD, Mu Y, et al. National Healthcare Safety Network (NHSN) report: data summary for 2006 through 2008, issued December 2009. Am J Infect Control. 2009;37(10):783–805.

    PubMed  Google Scholar 

  27. Maki DG, Goldman DA, Rhame FS. Infection control in intravenous therapy. Ann Intern Med. 1973;79(6):867–87.

    PubMed  CAS  Google Scholar 

  28. Maki D, Mermel L. Infections due to infusion therapy. CINA-AGINCOURT. 1999;15:71–95.

    Google Scholar 

  29. Douard MC, Clementi E, Arlet G, et al. Negative catheter-tip culture and diagnosis of catheter-related bacteremia. Nutrition. 1994;10(5):397–404.

    PubMed  CAS  Google Scholar 

  30. Nouwen JL, Wielenga JJ, van Overhagen H, et al. Hickman catheter-related infections in neutropenic patients: insertion in the operating theater versus insertion in the radiology suite. J Clin Oncol. 1999;17(4):1304.

    PubMed  CAS  Google Scholar 

  31. Livesley MA, Tebbs SE, Moss HA, Faroqui MH, Lambert PA, Elliott TS. Use of pulsed field gel electrophoresis to determine the source of microbial contamination of central venous catheters. Eur J Clin Microbiol Infect Dis. 1998;17(2):108–12.

    PubMed  CAS  Google Scholar 

  32. Darouiche RO, Raad II, Heard SO, et al. A comparison of two antimicrobial-impregnated central venous catheters. Catheter Study Group. N Engl J Med. 1999;340(1):1–8.

    PubMed  CAS  Google Scholar 

  33. Maki DG, Stolz SM, Wheeler S, Mermel LA. Prevention of central venous catheter-related bloodstream infection by use of an antiseptic-impregnated catheter. A randomized, controlled trial. Ann Intern Med. 1997;127(4):257–66.

    PubMed  CAS  Google Scholar 

  34. Garland JS, Alex CP, Sevallius JM, et al. Cohort study of the pathogenesis and molecular epidemiology of catheter-related bloodstream infection in neonates with peripherally inserted central venous catheters. Infect Control Hosp Epidemiol. 2008;29(3):243–9.

    PubMed  Google Scholar 

  35. Safdar N, Maki DG. The pathogenesis of catheter-related bloodstream infection with noncuffed short-term central venous catheters. Intensive Care Med. 2004;30(1):62–7.

    PubMed  Google Scholar 

  36. Marrie TJ, Costerton JW. Scanning and transmission electron microscopy of in situ bacterial colonization of intravenous and intraarterial catheters. J Clin Microbiol. 1984;19(5):687–93.

    PubMed  CAS  Google Scholar 

  37. Cooper GL, Schiller AL, Hopkins CC. Possible role of capillary action in pathogenesis of experimental catheter-associated dermal tunnel infections. J Clin Microbiol. 1988;26(1):8–12.

    PubMed  CAS  Google Scholar 

  38. Sitges-Serra A, Linares J, Garau J. Catheter sepsis: the clue is the hub. Surgery. 1985;97(3):355–7.

    PubMed  CAS  Google Scholar 

  39. Maki DG, Jarrett F, Sarafin HW. A semiquantitative culture method for identification of catheter-related infection in the burn patient. J Surg Res. 1977;22(5):513–20.

    PubMed  CAS  Google Scholar 

  40. Yokoe DS, Mermel LA, Anderson DJ, et al. A compendium of strategies to prevent healthcare-associated infections in acute care hospitals. Infect Control Hosp Epidemiol. 2008;29 Suppl 1:S12–21.

    PubMed  Google Scholar 

  41. Bjornson HS, Colley R, Bower RH, Duty VP, Schwartz-Fulton JT, Fischer JE. Association between microorganism growth at the catheter insertion site and colonization of the catheter in patients receiving total parenteral nutrition. Surgery. 1982;92(4):720–7.

    PubMed  CAS  Google Scholar 

  42. Sitges-Serra A, Puig P, Linares J, et al. Hub colonization as the initial step in an outbreak of catheter-related sepsis due to coagulase negative staphylococci during parenteral nutrition. JPEN J Parenter Enteral Nutr. 1984;8(6):668–72.

    PubMed  CAS  Google Scholar 

  43. Raad I, Costerton W, Sabharwal U, Sacilowski M, Anaissie E, Bodey GP. Ultrastructural analysis of indwelling vascular catheters: a quantitative relationship between luminal colonization and duration of placement. J Infect Dis. 1993;168(2):400–7.

    PubMed  CAS  Google Scholar 

  44. Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis. 2004;39(3):309–17.

    PubMed  Google Scholar 

  45. Trick WE, Fridkin SK, Edwards JR, Hajjeh RA, Gaynes RP. Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989–1999. Clin Infect Dis. 2002;35(5):627–30.

    PubMed  CAS  Google Scholar 

  46. Lorente L, Jimenez A, Santana M, et al. Microorganisms responsible for intravascular catheter-related bloodstream infection according to the catheter site. Crit Care Med. 2007;35(10):2424–7.

    PubMed  Google Scholar 

  47. Sipsas NV, Lewis RE, Tarrand J, et al. Candidemia in patients with hematologic malignancies in the era of new antifungal agents (2001–2007): stable incidence but changing epidemiology of a still frequently lethal infection. Cancer. 2009;115(20):4745–52.

    PubMed  CAS  Google Scholar 

  48. Safdar N, Maki DG. Use of vancomycin-containing lock or flush solutions for prevention of bloodstream infection associated with central venous access devices: a meta-analysis of prospective, randomized trials. Clin Infect Dis. 2006;43(4):474–84.

    PubMed  Google Scholar 

  49. Ho KM, Litton E. Use of chlorhexidine-impregnated dressing to prevent vascular and epidural catheter colonization and infection: a meta-analysis. J Antimicrob Chemother. 2006;58(2):281–7.

    PubMed  CAS  Google Scholar 

  50. Ramritu P, Halton K, Collignon P, et al. A systematic review comparing the relative effectiveness of antimicrobial-coated catheters in intensive care units. Am J Infect Control. 2008;36(2):104–17.

    PubMed  Google Scholar 

  51. Veenstra DL, Saint S, Saha S, Lumley T, Sullivan SD. Efficacy of antiseptic-impregnated central venous catheters in preventing catheter-related bloodstream infection: a meta-analysis. JAMA. 1999;281(3):261–7.

    PubMed  CAS  Google Scholar 

  52. Yahav D, Rozen-Zvi B, Gafter-Gvili A, Leibovici L, Gafter U, Paul M. Antimicrobial lock solutions for the prevention of infections associated with intravascular catheters in patients undergoing hemodialysis: systematic review and meta-analysis of randomized, controlled trials. Clin Infect Dis. 2008;47(1):83–93.

    PubMed  Google Scholar 

  53. Opilla MT, Kirby DF, Edmond MB. Use of ethanol lock therapy to reduce the incidence of catheter-related bloodstream infections in home parenteral nutrition patients. JPEN J Parenter Enteral Nutr. 2007;31(4):302–5.

    PubMed  Google Scholar 

  54. Chaiyakunapruk N, Veenstra DL, Lipsky BA, Saint S. Chlorhexidine compared with povidone-iodine solution for vascular catheter-site care: a meta-analysis. Ann Intern Med. 2002;136(11):792–801.

    PubMed  CAS  Google Scholar 

  55. Tacconelli E, Carmeli Y, Aizer A, Ferreira G, Foreman MG, D’Agata EM. Mupirocin prophylaxis to prevent Staphylococcus aureus infection in patients undergoing dialysis: a meta-analysis. Clin Infect Dis. 2003;37(12):1629–38.

    PubMed  CAS  Google Scholar 

  56. Safdar N, Crnich CJ, Maki DG. The pathogenesis of ventilator-associated pneumonia: its relevance to developing effective strategies for prevention. Respir Care. 2005;50(6):725–39. discussion 739–41.

    PubMed  Google Scholar 

  57. Clemence MA, Walker D, Farr BM. Central venous catheter practices: results of a survey. Am J Infect Control. 1995;23(1):5–12.

    PubMed  CAS  Google Scholar 

  58. Maki DG, Ringer M, Alvarado CJ. Prospective randomised trial of povidone-iodine, alcohol, and chlorhexidine for prevention of infection associated with central venous and arterial catheters. Lancet. 1991;338(8763):339–43.

    PubMed  CAS  Google Scholar 

  59. Wertheim HF, Vos MC, Ott A, et al. Mupirocin prophylaxis against nosocomial Staphylococcus aureus infections in nonsurgical patients: a randomized study. Ann Intern Med. 2004;140(6):419–25.

    PubMed  CAS  Google Scholar 

  60. Babu T, Rekasius V, Parada JP, Schreckenberger P, Challapalli M. Mupirocin resistance among methicillin-resistant Staphylococcus aureus-colonized patients at admission to a tertiary care medical center. J Clin Microbiol. 2009;47(7):2279–80.

    PubMed  CAS  Google Scholar 

  61. Orrett FA. The emergence of mupirocin resistance among clinical isolates of methicillin-resistant Staphylococcus aureus in Trinidad: a first report. Jpn J Infect Dis. 2008;61(2):107–10.

    PubMed  CAS  Google Scholar 

  62. Perkins D, Hogue JS, Fairchok M, Braun L, Viscount HB. Mupirocin resistance screening of methicillin-resistant Staphylococcus aureus isolates at Madigan Army Medical Center. Mil Med. 2008;173(6):604–8.

    PubMed  Google Scholar 

  63. Rossney A, O’Connell S. Emerging high-level mupirocin resistance among MRSA isolates in Ireland. Euro Surveill. 2008;13(14):8084.

    PubMed  Google Scholar 

  64. Graber CJ, Schwartz BS. Failure of decolonization in patients with infections due to mupirocin-resistant strains of community-associated methicillin-resistant Staphylococcus aureus. Infect Control Hosp Epidemiol. 2008;29(3):284. author reply 284–5.

    PubMed  Google Scholar 

  65. Cavdar C, Saglam F, Sifil A, et al. Effect of once-a-week vs thrice-a-week application of mupirocin on methicillin and mupirocin resistance in peritoneal dialysis patients: three years of experience. Ren Fail. 2008;30(4):417–22.

    PubMed  CAS  Google Scholar 

  66. Tang Z, Mazabob J, Weavind L, Thomas E, Johnson TR. A time-motion study of registered nurses’ workflow in intensive care unit remote monitoring. AMIA Annu Symp Proc. 2006:759–63.

    Google Scholar 

  67. Raad II, Hohn DC, Gilbreath BJ, et al. Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion. Infect Control Hosp Epidemiol. 1994;15(4 Pt 1):231–8.

    PubMed  CAS  Google Scholar 

  68. Mermel LA, McCormick RD, Springman SR, Maki DG. The pathogenesis and epidemiology of catheter-related infection with pulmonary artery Swan-Ganz catheters: a prospective study utilizing molecular subtyping. Am J Med. 1991;91(3B):197S–205.

    PubMed  CAS  Google Scholar 

  69. Goetz AM, Wagener MM, Miller JM, Muder RR. Risk of infection due to central venous catheters: effect of site of placement and catheter type. Infect Control Hosp Epidemiol. 1998;19(11): 842–5.

    PubMed  CAS  Google Scholar 

  70. Joynt GM, Kew J, Gomersall CD, Leung VY, Liu EK. Deep venous thrombosis caused by femoral venous catheters in critically ill adult patients. Chest. 2000;117(1):178–83.

    PubMed  CAS  Google Scholar 

  71. Merrer J, De Jonghe B, Golliot F, et al. Complications of femoral and subclavian venous catheterization in critically ill patients: a randomized controlled trial. JAMA. 2001;286(6):700–7.

    PubMed  CAS  Google Scholar 

  72. Richet H, Hubert B, Nitemberg G, et al. Prospective multicenter study of vascular-catheter-related complications and risk factors for positive central-catheter cultures in intensive care unit patients. J Clin Microbiol. 1990;28(11):2520–5.

    PubMed  CAS  Google Scholar 

  73. Do AN, Ray BJ, Banerjee SN, et al. Bloodstream infection associated with needleless device use and the importance of infection-control practices in the home health care setting. J Infect Dis. 1999;179(2):442–8.

    PubMed  CAS  Google Scholar 

  74. Gowardman JR, Robertson IK, Parkes S, Rickard CM. Influence of insertion site on central venous catheter colonization and bloodstream infection rates. Intensive Care Med. 2008;34(6):1038–45.

    PubMed  Google Scholar 

  75. Parienti JJ, Thirion M, Megarbane B, et al. Femoral vs jugular venous catheterization and risk of nosocomial events in adults requiring acute renal replacement therapy: a randomized controlled trial. JAMA. 2008;299(20):2413–22.

    PubMed  CAS  Google Scholar 

  76. Randolph AG, Cook DJ, Gonzales CA, Pribble CG. Ultrasound guidance for placement of central venous catheters: a meta-analysis of the literature. Crit Care Med. 1996;24(12):2053–8.

    PubMed  CAS  Google Scholar 

  77. Karakitsos D, Labropoulos N, De Groot E, et al. Real-time ultrasound-guided catheterisation of the internal jugular vein: a prospective comparison with the landmark technique in critical care patients. Crit Care. 2006;10(6):R162.

    PubMed  Google Scholar 

  78. Barsuk JH, Cohen ER, Feinglass J, McGaghie WC, Wayne DB. Use of simulation-based education to reduce catheter-related bloodstream infections. Arch Intern Med. 2009;169(15):1420–3.

    PubMed  Google Scholar 

  79. Maki DG, Mermel LA, Kluger D, Narans L, Knasinski V, Parenteau S, Covington P. The efficacy of a chlorhexidine impregnated sponge (Biopatch) for the prevention of intravascular catheter-related infection-a prospective randomized controlled multicenter study. 2000.

    Google Scholar 

  80. Timsit JF, Cheval C, Gachot B, et al. Usefulness of a strategy based on bronchoscopy with direct examination of bronchoalveolar lavage fluid in the initial antibiotic therapy of suspected ventilator-associated pneumonia. Intensive Care Med. 2001; 27(4):640–7.

    PubMed  CAS  Google Scholar 

  81. Ruschulte H, Franke M, Gastmeier P, et al. Prevention of central venous catheter related infections with chlorhexidine gluconate impregnated wound dressings: a randomized controlled trial. Ann Hematol. 2009;88(3):267–72.

    PubMed  CAS  Google Scholar 

  82. Bleasdale SC, Trick WE, Gonzalez IM, Lyles RD, Hayden MK, Weinstein RA. Effectiveness of chlorhexidine bathing to reduce catheter-associated bloodstream infections in medical intensive care unit patients. Arch Intern Med. 2007;167(19):2073–9.

    PubMed  Google Scholar 

  83. Borer A, Gilad J, Porat N, et al. Impact of 4% chlorhexidine whole-body washing on multidrug-resistant Acinetobacter baumannii skin colonisation among patients in a medical intensive care unit. J Hosp Infect. 2007;67(2):149–55.

    PubMed  CAS  Google Scholar 

  84. Climo MW, Sepkowitz KA, Zuccotti G, et al. The effect of daily bathing with chlorhexidine on the acquisition of methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and healthcare-associated bloodstream infections: results of a quasi-experimental multicenter trial. Crit Care Med. 2009;37(6):1858–65.

    PubMed  CAS  Google Scholar 

  85. Camus C, Bellissant E, Sebille V, et al. Prevention of acquired infections in intubated patients with the combination of two decontamination regimens. Crit Care Med. 2005;33:307–14.

    PubMed  Google Scholar 

  86. Evans H, Dellit T, Chan J, Nathens A, Maier R, Cuschieri J. Effect of chlorhexidine whole-body bathing on hospital-acquired infections among trauma patients. Arch Surg. 2010;145(3):240.

    PubMed  CAS  Google Scholar 

  87. Gould IM, MacKenzie FM, MacLennan G, Pacitti D, Watson EJ, Noble DW. Topical antimicrobials in combination with admission screening and barrier precautions to control endemic methicillin-resistant Staphylococcus aureus in an intensive care unit. Int J Antimicrob Agents. 2007;29(5):536–43.

    PubMed  CAS  Google Scholar 

  88. Holder C, Zellinger M. Daily bathing with chlorhexidine in the ICU to prevent central line-associated bloodstream infections. JCOM. 2009;16(11):509–13.

    Google Scholar 

  89. Munoz Price L, Hota B, Stemer A, Weinstein R. Prevention of bloodstream infections by use of daily chlorhexidine baths for patients at a long term acute care hospital. Infect Control Hosp Epidemiol. 2009;30:1031–5.

    PubMed  Google Scholar 

  90. Popovich KJ, Hota B, Hayes R, Weinstein RA, Hayden MK. Effectiveness of routine patient cleansing with chlorhexidine gluconate for infection prevention in the medical intensive care unit. Infect Control Hosp Epidemiol. 2009;30(10):959–63.

    PubMed  Google Scholar 

  91. Casey AL, Mermel LA, Nightingale P, Elliott TS. Antimicrobial central venous catheters in adults: a systematic review and meta-analysis. Lancet Infect Dis. 2008;8(12):763–76.

    PubMed  CAS  Google Scholar 

  92. Sanders J, Pithie A, Ganly P, et al. A prospective double-blind randomized trial comparing intraluminal ethanol with heparinized saline for the prevention of catheter-associated bloodstream infection in immunosuppressed haematology patients. J Antimicrob Chemother. 2008;62(4):809–15.

    PubMed  CAS  Google Scholar 

  93. Bookstaver PB, Williamson JC, Tucker BK, Raad II, Sherertz RJ. Activity of novel antibiotic lock solutions in a model against isolates of catheter-related bloodstream infections. Ann Pharmacother. 2009;43(2):210–9.

    PubMed  CAS  Google Scholar 

  94. Mendelson MH, Short LJ, Schechter CB, et al. Study of a needleless intermittent intravenous-access system for peripheral infusions: analysis of staff, patient, and institutional outcomes. Infect Control Hosp Epidemiol. 1998;19(6):401–6.

    PubMed  CAS  Google Scholar 

  95. Skolnick R, LaRocca J, Barba D, Paicius L. Evaluation and implementation of a needleless intravenous system: making needlesticks a needless problem. Am J Infect Control. 1993;21(1):39–41.

    PubMed  CAS  Google Scholar 

  96. Gartner K. Impact of a needleless intravenous system in a university hospital. J Healthc Mater Manage. 1993;11(8):44–6, 48–9.

    Google Scholar 

  97. Lawrence D. HAI – a high visibility problem: recent studies show that hospitals with low HAI rates rely heavily on IT, but the jury is still out on where a CIO should begin. Healthc Inform. 2008;25(12):22–24.

    Google Scholar 

  98. Cookson ST, Ihrig M, O’Mara EM, et al. Increased bloodstream infection rates in surgical patients associated with variation from recommended use and care following implementation of a needleless device. Infect Control Hosp Epidemiol. 1998;19(1):23–7.

    PubMed  CAS  Google Scholar 

  99. McDonald LC, Banerjee SN, Jarvis WR. Line-associated bloodstream infections in pediatric intensive-care-unit patients associated with a needleless device and intermittent intravenous therapy. Infect Control Hosp Epidemiol. 1998;19(10):772–7.

    PubMed  CAS  Google Scholar 

  100. Kellerman S, Shay DK, Howard J, et al. Bloodstream infections in home infusion patients: the influence of race and needleless intravascular access devices. J Pediatr. 1996;129(5):711–7.

    PubMed  CAS  Google Scholar 

  101. Rupp ME, Sholtz LA, Jourdan DR, et al. Outbreak of bloodstream infection temporally associated with the use of an intravascular needleless valve. Clin Infect Dis. 2007;44(11):1408–14.

    PubMed  Google Scholar 

  102. Maragakis LL, Bradley KL, Song X, et al. Increased catheter-related bloodstream infection rates after the introduction of a new mechanical valve intravenous access port. Infect Control Hosp Epidemiol. 2006;27(1):67–70.

    PubMed  Google Scholar 

  103. Casey AL, Worthington T, Lambert PA, Quinn D, Faroqui MH, Elliott TS. A randomized, prospective clinical trial to assess the potential infection risk associated with the PosiFlow needleless connector. J Hosp Infect. 2003;54(4):288–93.

    PubMed  CAS  Google Scholar 

  104. Menyhay SZ, Maki DG. Disinfection of needleless catheter connectors and access ports with alcohol may not prevent microbial entry: the promise of a novel antiseptic-barrier cap. Infect Control Hosp Epidemiol. 2006;27(1):23–7.

    PubMed  Google Scholar 

  105. Maki DG. In vitro studies of a novel antimicrobial luer-activated needleless connector for prevention of catheter-related bloodstream infection. Clin Infect Dis. 2010;50(12):1580–7.

    PubMed  Google Scholar 

  106. Menyhay SZ, Maki DG. Preventing central venous catheter-associated bloodstream infections: development of an antiseptic barrier cap for needleless connectors. Am J Infect Control. 2008;36(10):S174, e1–5.

    Google Scholar 

  107. Schears GJ. Summary of product trials for 10, 164 patients: comparing an intravenous stabilizing device to tape. J Infus Nurs. 2006;29(4):225–31.

    PubMed  Google Scholar 

  108. Yamamoto AJ, Solomon JA, Soulen MC, et al. Sutureless securement device reduces complications of peripherally inserted central venous catheters. J Vasc Interv Radiol. 2002;13(1):77–81.

    PubMed  Google Scholar 

  109. Frey AM, Schears GJ. Why are we stuck on tape and suture? A review of catheter securement devices. J Infus Nurs. 2006;29(1):34–8.

    PubMed  Google Scholar 

  110. van den Berghe G, Wouters P, Weekers F, et al. Intensive insulin therapy in the critically ill patients. N Engl J Med. 2001;345(19):1359–67.

    PubMed  Google Scholar 

  111. Van den Berghe G, Wilmer A, Hermans G, et al. Intensive insulin therapy in the medical ICU. N Engl J Med. 2006;354(5):449–61.

    PubMed  Google Scholar 

  112. Wiener RS, Wiener DC, Larson RJ. Benefits and risks of tight glucose control in critically ill adults: a meta-analysis. JAMA. 2008;300(8):933–44.

    PubMed  CAS  Google Scholar 

  113. Finfer S, Chittock DR, Su SY, et al. Intensive versus conventional glucose control in critically ill patients. N Engl J Med. 2009;360(13):1283–97.

    PubMed  Google Scholar 

  114. Griesdale DE, de Souza RJ, van Dam RM, et al. Intensive insulin therapy and mortality among critically ill patients: a meta-analysis including NICE-SUGAR study data. CMAJ. 2009;180(8):821–7.

    PubMed  Google Scholar 

  115. Haraden C. What is a bundle? 09/07/2006 ed: Institute for Healthcare Improvement. 2006.

    Google Scholar 

  116. Bhutta A, Gilliam C, Honeycutt M, et al. Reduction of bloodstream infections associated with catheters in paediatric intensive care unit: stepwise approach. BMJ. 2007;334(7589):362–5.

    PubMed  Google Scholar 

  117. Costello JM, Morrow DF, Graham DA, Potter-Bynoe G, Sandora TJ, Laussen PC. Systematic intervention to reduce central line-associated bloodstream infection rates in a pediatric cardiac intensive care unit. Pediatrics. 2008;121(5):915–23.

    PubMed  Google Scholar 

  118. Mermel LA, Farr BM, Sherertz RJ, et al. Guidelines for the management of intravascular catheter-related infections. J Intraven Nurs. 2001;24(3):180–205.

    PubMed  CAS  Google Scholar 

  119. Heard SO, Wagle M, Vijayakumar E, et al. Influence of triple-lumen central venous catheters coated with chlorhexidine and silver sulfadiazine on the incidence of catheter-related bacteremia. Arch Intern Med. 1998;158(1):81–7.

    PubMed  CAS  Google Scholar 

  120. Kassar R, Hachem R, Jiang Y, Chaftari AM, Raad I. Management of Bacillus bacteremia: the need for catheter removal. Medicine (Baltimore). 2009;88(5):279–83.

    Google Scholar 

  121. Bouza E, Burillo A, Munoz P. Catheter-related infections: diagnosis and intravascular treatment. J Chemother. 2001;13 Spec No 1(1):224–33.

    Google Scholar 

  122. Carratala J. Role of antibiotic prophylaxis for the prevention of intravascular catheter-related infection. Clin Microbiol Infect. 2001;7 Suppl 4:83–90.

    PubMed  Google Scholar 

  123. Capdevila JA. Catheter-related infection: an update on diagnosis, treatment, and prevention. Int J Infect Dis. 1998;2(4):230–6.

    PubMed  CAS  Google Scholar 

  124. Allon M. Saving infected catheters: why and how. Blood Purif. 2005;23(1):23–8.

    PubMed  Google Scholar 

  125. Aslam S, Trautner BW, Ramanathan V, Darouiche RO. Pilot trial of N-acetylcysteine and tigecycline as a catheter-lock solution for treatment of hemodialysis catheter-associated bacteremia. Infect Control Hosp Epidemiol. 2008;29(9):894–7.

    PubMed  Google Scholar 

  126. Battistella M, Walker S, Law S, Lok C. Antibiotic lock: in vitro stability of vancomycin and four percent sodium citrate stored in dialysis catheters at 37 degrees C. Hemodial Int. 2009;13(3):322–8.

    PubMed  Google Scholar 

  127. Bestul MB, Vandenbussche HL. Antibiotic lock technique: review of the literature. Pharmacotherapy. 2005;25(2):211–27.

    PubMed  CAS  Google Scholar 

  128. Bregenzer T, Widmer AF. Bloodstream infection from a Port-A-Cath: successful treatment with the antibiotic lock technique. Infect Control Hosp Epidemiol. 1996;17(12):772.

    PubMed  CAS  Google Scholar 

  129. Broom J, Woods M, Allworth A, et al. Ethanol lock therapy to treat tunnelled central venous catheter-associated blood stream infections: results from a prospective trial. Scand J Infect Dis. 2008;40(5):399–406.

    PubMed  CAS  Google Scholar 

  130. Buckler BS, Sams RN, Goei VL, et al. Treatment of central venous catheter fungal infection using liposomal amphotericin-B lock therapy. Pediatr Infect Dis J. 2008;27(8):762–4.

    PubMed  Google Scholar 

  131. Carratala J. The antibiotic-lock technique for therapy of “highly needed” infected catheters. Clin Microbiol Infect. 2002;8(5):282–9.

    PubMed  CAS  Google Scholar 

  132. Castagnola E, Moroni C, Gandullia P, et al. Catheter lock and systemic infusion of linezolid for treatment of persistent Broviac catheter-related staphylococcal bacteremia. Antimicrob Agents Chemother. 2006;50(3):1120–1.

    PubMed  CAS  Google Scholar 

  133. Cuntz D, Michaud L, Guimber D, Husson MO, Gottrand F, Turck D. Local antibiotic lock for the treatment of infections related to central catheters in parenteral nutrition in children. JPEN J Parenter Enteral Nutr. 2002;26(2):104–8.

    PubMed  CAS  Google Scholar 

  134. Dannenberg C, Bierbach U, Rothe A, Beer J, Korholz D. Ethanol-lock technique in the treatment of bloodstream infections in pediatric oncology patients with broviac catheter. J Pediatr Hematol Oncol. 2003;25(8):616–21.

    PubMed  Google Scholar 

  135. del Pozo JL. Role of antibiotic lock therapy for the treatment of catheter-related bloodstream infections. Int J Artif Organs. 2009;32(9):678–88.

    PubMed  Google Scholar 

  136. Del Pozo JL, Alonso M, Serrera A, Hernaez S, Aguinaga A, Leiva J. Effectiveness of the antibiotic lock therapy for the treatment of port-related enterococci, Gram-negative, or Gram-positive bacilli bloodstream infections. Diagn Microbiol Infect Dis. 2009;63(2):208–12.

    PubMed  Google Scholar 

  137. Elwood RL, Spencer SE. Successful clearance of catheter-related bloodstream infection by antibiotic lock therapy using ampicillin. Ann Pharmacother. 2006;40(2):347–50.

    PubMed  Google Scholar 

  138. Fernandez-Hidalgo N, Almirante B, Calleja R, et al. Antibiotic-lock therapy for long-term intravascular catheter-related bacteraemia: results of an open, non-comparative study. J Antimicrob Chemother. 2006;57(6):1172–80.

    PubMed  CAS  Google Scholar 

  139. Fortun J, Grill F, Martin-Davila P, et al. Treatment of long-term intravascular catheter-related bacteraemia with antibiotic-lock therapy. J Antimicrob Chemother. 2006;58(4):816–21.

    PubMed  CAS  Google Scholar 

  140. Kentos A, Struelens MJ, Thys JP. Antibiotic-lock technique for the treatment of central venous catheter infections. Clin Infect Dis. 1996;23(2):418–9.

    PubMed  CAS  Google Scholar 

  141. Maya ID. Antibiotic lock for treatment of tunneled hemodialysis catheter bacteremia. Semin Dial. 2008;21(6):539–41.

    PubMed  Google Scholar 

  142. Maya ID, Carlton D, Estrada E, Allon M. Treatment of dialysis catheter-related Staphylococcus aureus bacteremia with an antibiotic lock: a quality improvement report. Am J Kidney Dis. 2007;50(2):289–95.

    PubMed  CAS  Google Scholar 

  143. Megged O, Shalit I, Yaniv I, Fisher S, Livni G, Levy I. Outcome of antibiotic lock technique for persistent central venous catheter-associated coagulase-negative Staphylococcus bacteremia in children. Eur J Clin Microbiol Infect Dis. 2010;29(2):157–61.

    PubMed  CAS  Google Scholar 

  144. Messing B. Catheter-related sepsis during home parenteral nutrition. Clin Nutr. 1995;14 Suppl 1:46–51.

    PubMed  Google Scholar 

  145. Messing B, Man F, Colimon R, Thuillier F, Beliah M. Antibiotic-lock technique is an effective treatment of bacterial catheter-related sepsis during parenteral nutrition. Clin Nutr. 1990;9(4):220–5.

    PubMed  CAS  Google Scholar 

  146. Pagani JL, Eggimann P. Management of catheter-related infection. Expert Rev Anti Infect Ther. 2008;6(1):31–7.

    PubMed  Google Scholar 

  147. Poole CV, Carlton D, Bimbo L, Allon M. Treatment of catheter-related bacteraemia with an antibiotic lock protocol: effect of bacterial pathogen. Nephrol Dial Transplant. 2004;19(5):1237–44.

    PubMed  CAS  Google Scholar 

  148. Viale P, Pagani L, Petrosillo N, et al. Antibiotic lock-technique for the treatment of catheter-related bloodstream infections. J Chemother. 2003;15(2):152–6.

    PubMed  CAS  Google Scholar 

  149. Rijnders BJ, Van Wijngaerden E, Vandecasteele SJ, Stas M, Peetermans WE. Treatment of long-term intravascular catheter-related bacteraemia with antibiotic lock: randomized, placebo-controlled trial. J Antimicrob Chemother. 2005;55(1):90–4.

    PubMed  CAS  Google Scholar 

  150. Droste JC, Jeraj HA, MacDonald A, Farrington K. Stability and in vitro efficacy of antibiotic-heparin lock solutions potentially useful for treatment of central venous catheter-related sepsis. J Antimicrob Chemother. 2003;51(4):849–55.

    PubMed  CAS  Google Scholar 

  151. Maiefski M, Rupp ME, Hermsen ED. Ethanol lock technique: review of the literature. Infect Control Hosp Epidemiol. 2009;30(11):1096–108.

    PubMed  Google Scholar 

  152. Shaffer D. Catheter-related sepsis complicating long-term, tunnelled central venous dialysis catheters: management by guidewire exchange. Am J Kidney Dis. 1995;25(4):593–6.

    PubMed  CAS  Google Scholar 

  153. Carlisle EJ, Blake P, McCarthy F, Vas S, Uldall R. Septicemia in long-term jugular hemodialysis catheters; eradicating infection by changing the catheter over a guidewire. Int J Artif Organs. 1991;14(3):150–3.

    PubMed  CAS  Google Scholar 

  154. Martinez E, Mensa J, Rovira M, et al. Central venous catheter exchange by guidewire for treatment of catheter-related bacteraemia in patients undergoing BMT or intensive chemotherapy. Bone Marrow Transplant. 1999;23(1):41–4.

    PubMed  CAS  Google Scholar 

  155. Raad I, Hanna H, Boktour M, et al. Management of central venous catheters in patients with cancer and candidemia. Clin Infect Dis. 2004;38(8):1119–27.

    PubMed  Google Scholar 

  156. Shuford JA, Rouse MS, Piper KE, Steckelberg JM, Patel R. Evaluation of caspofungin and amphotericin B deoxycholate against Candida albicans biofilms in an experimental intravascular catheter infection model. J Infect Dis. 2006;194(5):710–3.

    PubMed  CAS  Google Scholar 

  157. Bachmann SP, Ramage G, VandeWalle K, Patterson TF, Wickes BL, Lopez-Ribot JL. Antifungal combinations against Candida albicans biofilms in vitro. Antimicrob Agents Chemother. 2003;47(11):3657–9.

    PubMed  CAS  Google Scholar 

  158. Ghanem GA, Boktour M, Warneke C, et al. Catheter-related Staphylococcus aureus bacteremia in cancer patients: high rate of complications with therapeutic implications. Medicine (Baltimore). 2007;86(1):54–60.

    Google Scholar 

  159. Nolan CM, Beaty HN. Staphylococcus aureus bacteremia. Current clinical patterns. Am J Med. 1976;60(4):495–500.

    PubMed  CAS  Google Scholar 

  160. Rosen AB, Fowler Jr VG, Corey GR, et al. Cost-effectiveness of transesophageal echocardiography to determine the duration of therapy for intravascular catheter-associated Staphylococcus aureus bacteremia. Ann Intern Med. 1999;130(10):810–20.

    PubMed  CAS  Google Scholar 

  161. Jacob S, Tong AT. Role of echocardiography in the diagnosis and management of infective endocarditis. Curr Opin Cardiol. 2002;17(5):478–85.

    PubMed  Google Scholar 

  162. Rajpurkar M, Boldt-Macdonald K, McLenon R, et al. Ethanol lock therapy for the treatment of catheter-related infections in haemophilia patients. Haemophilia. 2009;15(6):1267–71.

    PubMed  CAS  Google Scholar 

  163. Santarpia L, Pasanisi F, Alfonsi L, et al. Prevention and treatment of implanted central venous catheter (CVC)-related sepsis: a report after six years of home parenteral nutrition (HPN). Clin Nutr. 2002;21(3):207–11.

    PubMed  Google Scholar 

  164. Saxena AK, Panhotra BR, Sundaram DS, Morsy MN, Al-Ghamdi AM. Enhancing the survival of tunneled haemodialysis catheters using an antibiotic lock in the elderly: a randomised, double-blind clinical trial. Nephrology (Carlton). 2006;11(4):299–305.

    CAS  Google Scholar 

  165. Simon A, Bode U, Beutel K. Diagnosis and treatment of catheter-related infections in paediatric oncology: an update. Clin Microbiol Infect. 2006;12(7):606–20.

    PubMed  CAS  Google Scholar 

  166. Toltzis P. Antibiotic lock technique to reduce central venous catheter-related bacteremia. Pediatr Infect Dis J. 2006;25(5):449–50.

    PubMed  Google Scholar 

  167. Williams N, Carlson GL, Scott NA, Irving MH. Incidence and management of catheter-related sepsis in patients receiving home parenteral nutrition. Br J Surg. 1994;81(3):392–4.

    PubMed  CAS  Google Scholar 

  168. Mermel LA, Allon M, Bouza E, et al. Clinical practice guidelines for the diagnosis and management of intravascular catheter-related infection: 2009 update by the Infectious Diseases Society of America. Clin Infect Dis. 2009;49(1):1–45.

    PubMed  CAS  Google Scholar 

  169. Raad I, Kassar R, Ghannam D, Chaftari AM, Hachem R, Jiang Y. Management of the catheter in documented catheter-related coagulase-negative staphylococcal bacteremia: remove or retain? Clin Infect Dis. 2009;49(8):1187–94.

    PubMed  Google Scholar 

  170. Nadkarni AS, Schliep T, Khan L, Zeana CB. Cluster of bloodstream infections caused by KPC-2 carbapenemase-producing Klebsiella pneumoniae in Manhattan. Am J Infect Control. 2009;37(2):121–6.

    PubMed  Google Scholar 

  171. Gasink LB, Fishman NO, Nachamkin I, Bilker WB, Lautenbach E. Risk factors for and impact of infection or colonization with aztreonam-resistant Pseudomonas aeruginosa. Infect Control Hosp Epidemiol. 2007;28(10):1175–80.

    PubMed  Google Scholar 

  172. Lautenbach E, Patel JB, Bilker WB, Edelstein PH, Fishman NO. Extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae: risk factors for infection and impact of resistance on outcomes. Clin Infect Dis. 2001;32(8):1162–71.

    PubMed  CAS  Google Scholar 

  173. Lautenbach E, Weiner MG, Nachamkin I, Bilker WB, Sheridan A, Fishman NO. Imipenem resistance among Pseudomonas aeruginosa isolates: risk factors for infection and impact of resistance on clinical and economic outcomes. Infect Control Hosp Epidemiol. 2006;27(9):893–900.

    PubMed  Google Scholar 

  174. Crnich CJ, Maki DG. The promise of novel technology for the prevention of intravascular device-related bloodstream infection. II. Long-term devices. Clin Infect Dis. 2002;34(10):1362–8.

    PubMed  Google Scholar 

  175. O’Grady NP, Alexander M, Dellinger EP, et al. Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention. MMWR Recomm Rep. 2002;51(RR-10):1–29.

    PubMed  Google Scholar 

  176. Hockenhull JC, Dwan KM, Smith GW, et al. The clinical effectiveness of central venous catheters treated with anti-infective agents in preventing catheter-related bloodstream infections: a systematic review. Crit Care Med. 2009;37(2):702–12.

    PubMed  CAS  Google Scholar 

  177. Onder AM, Chandar J, Billings AA, et al. Comparison of early versus late use of antibiotic locks in the treatment of catheter-related bacteremia. Clin J Am Soc Nephrol. 2008;3(4):1048–56.

    PubMed  Google Scholar 

  178. Vaughan LM, Poon CY. Stability of ceftazidime and vancomycin alone and in combination in heparinized and nonheparinized peritoneal dialysis solution. Ann Pharmacother. 1994;28(5):572–6.

    PubMed  CAS  Google Scholar 

  179. Fowler Jr VG, Li J, Corey GR, et al. Role of echocardiography in evaluation of patients with Staphylococcus aureus bacteremia: experience in 103 patients. J Am Coll Cardiol. 1997;30(4):1072–8.

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Section of Infectious Diseases, Department of Medicine, University of Wisconsin Medical School, MFCB 5221, 1685 Highland Avenue, Madison, WI, 53717, USA

    Nasia Safdar

Authors
  1. Nasia Safdar
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dennis G. Maki
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Nasia Safdar .

Editor information

Editors and Affiliations

  1. MD Anderson Cancer Center, Infectious Diseases Department, The University of Texas, 800 5th Avenue, Apt. 12-G, New York, 10065, New York, USA

    Amar Safdar

Rights and permissions

Reprints and permissions

Copyright information

© 2011 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Safdar, N., Maki, D.G. (2011). Intravascular Device-Related Infections: Catheter Salvage Strategies and Prevention of Device-Related Infection. In: Safdar, A. (eds) Principles and Practice of Cancer Infectious Diseases. Current Clinical Oncology. Humana Press, Totowa, NJ. https://doi.org/10.1007/978-1-60761-644-3_11

Download citation

  • DOI: https://doi.org/10.1007/978-1-60761-644-3_11

  • Published:

  • Publisher Name: Humana Press, Totowa, NJ

  • Print ISBN: 978-1-60761-643-6

  • Online ISBN: 978-1-60761-644-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation